Intravenous Sotalol in Pediatric Intensive Care Patients With and Without Congenital Heart Disease: Hemodynamic and Antiarrhythmic Effects
- 24 February 2026
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- p. 1-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Sotalol versus amiodarone for postoperative junctional tachycardia after congenital heart surgeryHeart Rhythm, 2022
- Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane OxygenationPediatric Cardiology, 2019
- Cardiovascular Collapse with Intravenous Amiodarone in Children: A Multi-Center Retrospective Cohort StudyPediatric Cardiology, 2019
- Early experience with intravenous sotalol in children with and without congenital heart diseaseHeart Rhythm, 2018
- Intravenous sotalol for the management of postoperative junctional ectopic tachycardiaHeartRhythm Case Reports, 2018
- Intravenous sotalol for conversion of atrial flutter in infantsHeartRhythm Case Reports, 2018
- Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with ArrhythmiaPediatric Cardiology, 2017
- Use of intravenous sotalol in newborns with supraventricular tachycardiaHeartRhythm Case Reports, 2017
- Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in ChildrenThe American Journal of Cardiology, 2017
- Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalolThe American Journal of Cardiology, 1993